These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Clinical pharmacology of antiarrhythmic drugs: variability of metabolism and dose requirements. Follath F J Cardiovasc Pharmacol; 1991; 17 Suppl 6():S74-6. PubMed ID: 1723123 [TBL] [Abstract][Full Text] [Related]
3. Therapeutic monitoring of antiarrhythmic drugs. Kates RE Ther Drug Monit; 1980; 2(2):119-26. PubMed ID: 6762707 [TBL] [Abstract][Full Text] [Related]
4. The utility of serum drug level monitoring during therapy with class III antiarrhythmic agents. Follath F J Cardiovasc Pharmacol; 1992; 20 Suppl 2():S41-3. PubMed ID: 1279308 [TBL] [Abstract][Full Text] [Related]
5. Role of plasma concentration monitoring in the evaluation of response to antiarrhythmic drugs. Woosley RL Am J Cardiol; 1988 Oct; 62(12):9H-17H. PubMed ID: 3052009 [TBL] [Abstract][Full Text] [Related]
6. Response optimization of drug dosage: antiarrhythmic studies with tocainide. Meffin PJ; Winkle RA; Blaschke TF; Fitzgerald J; Harrison DC; Harapat SR; Bell PA Clin Pharmacol Ther; 1977 Jul; 22(1):42-57. PubMed ID: 872495 [TBL] [Abstract][Full Text] [Related]
7. Appropriate dosing of antiarrhythmic drugs in Japan requires therapeutic drug monitoring. Takada M; Goto T; Kotake T; Saito M; Kawato N; Nakai M; Gunji T; Shibakawa M J Clin Pharm Ther; 2005 Feb; 30(1):5-12. PubMed ID: 15658999 [TBL] [Abstract][Full Text] [Related]
8. Pharmacology of antiarrhythmic drugs for the clinician--medical emergencies and chronic treatment. Storstein L Eur Heart J; 1984 Sep; 5 Suppl B():59-62. PubMed ID: 6499872 [TBL] [Abstract][Full Text] [Related]
9. [Plasma levels of anti-arrhythmic drugs and clinical effectiveness in the treatment of ventricular arrhythmias]. Bracchetti D; Naccarella F; Guaragna RF; Palmieri M; Bartoletti A; Barbato G; Malini PL; Marchesini B; Ambrosioni E G Ital Cardiol; 1986 Aug; 16(8):648-59. PubMed ID: 3539687 [TBL] [Abstract][Full Text] [Related]
10. Clinical application of pharmacokinetics for antiarrhythmic drugs. Harrison DC Arch Mal Coeur Vaiss; 1981 Dec; 74 Spec No():65-72. PubMed ID: 6803703 [TBL] [Abstract][Full Text] [Related]
11. [Determination of plasma concentrations of anti-arrhythmia agents]. Flouvat B Arch Mal Coeur Vaiss; 1981 Dec; 74 Spec No():47-55. PubMed ID: 6803701 [TBL] [Abstract][Full Text] [Related]
12. Clinical value of plasma concentrations of antiarrhythmic drugs. Edvardsson N; Olsson SB Eur Heart J; 1987 Mar; 8 Suppl A():83-9. PubMed ID: 3556180 [TBL] [Abstract][Full Text] [Related]
13. Classification and pharmacology of antiarrhythmic drugs. Kowey PR; Marinchak RA; Rials SJ; Bharucha DB Am Heart J; 2000 Jul; 140(1):12-20. PubMed ID: 10874257 [TBL] [Abstract][Full Text] [Related]
14. [Antiarrhythmic therapy in patients with heart failure]. Faber TS; Zehender M Ther Umsch; 2000 May; 57(5):324-32. PubMed ID: 10859993 [TBL] [Abstract][Full Text] [Related]
15. Initial experience with antiarrhythmic medication monitoring by clinical pharmacists in an outpatient setting: a retrospective review. Snider M; Kalbfleisch S; Carnes CA Clin Ther; 2009 Jun; 31(6):1209-18. PubMed ID: 19695388 [TBL] [Abstract][Full Text] [Related]
16. [Therapeutic Drug Monitoring of Antiarrhythmic Drugs]. Takahashi N Rinsho Byori; 2016 Dec; 64(12):1390-1394. PubMed ID: 30653903 [TBL] [Abstract][Full Text] [Related]
17. Transtelephone adjustment of antiarrhythmic therapy in ambulatory patients. Hasin Y; David D; Rogel S Cardiology; 1978; 63(4):243-51. PubMed ID: 657175 [TBL] [Abstract][Full Text] [Related]
20. New drugs in the management of ventricular arrhythmias. Sanna GP G Ital Cardiol; 1984 Oct; 14(10):788-97. PubMed ID: 6083894 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]